Latest issue of Hampshire & IOW Medicines Optimisation Bulletin

This bulletin is predominantly aimed at GP surgeries, but the information is useful to know.

The latest bulletin contains information on the following:

• Rivastigmine transdermal patch: Risk of medication error when switching between formulations
• MHRA drug safety update: Finasteride and dutasteride – updated safety warnings for psychiatric side effects and sexual dysfunction
• MHRA drug safety update: Nasal decongestant sprays and drops containing xylometazoline hydrochloride / oxymetazoline hydrochloride: increased risk of rebound congestion, rhinitis medicamentosa, and tachyphylaxis with overuse
• ADHD in Adult and Children Shared Care Guidelines (SCG)
• PGD for Salbutamol use in spirometry
• Back-up antibiotic prescribing guidance for primary care
• Anaphylaxis: assessment and referral after emergency treatment updated guidance (NG258)
• Neonatal infection: antibiotics for prevention and treatment updated guidance (NG195)
• Acne vulgaris: management updated guidance (NG198)
• Pharmacological management of migraine: updated guideline (SIGN 155)
• SPS update: Switching doxazosin XL tablets to doxazosin standard tablets
• An introduction to drug allergy with a focus on penicillin allergy de-labelling (PADL) 25 June 2026 | 1-2pm – Registration link

Download the bulletin here for more information and links:

• https://cpsc.org.uk/download_file/view/5701/3862